Brief: Enorama Pharma Appoints Daniel Schröder As CEO
June 24 (Reuters) - Enorama Pharma AB ERMA.ST :
* DANIEL SCHRÖDER APPOINTED AS CEO
* SCHRÖDER WILL TAKE UP POSITION OF CEO ON 5 AUGUST 2024 AND
WILL
RESIGN FROM BOARD OF DIRECTORS
Source text for Eikon: ID:nWkr2bQrvk
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO